Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly

J. van der Lely, A.; Gomez, R.; Pleil, A.; Badia, X.; Brue, T.; Buchfelder, M.; Burman, P.; Clemmons, D.; Ghigo, E.; Otto Lunde Jørgensen, Jens; Luger, A.; van der Lans-Bussemaker, J.; Webb, S.; Strasburger, C.

doi:10.1007/s11102-017-0835-5

Public

Development of ACRODAT®, a new software medical device to assess disease activity in patients with acromegaly

Published in Pituitary • Sep 8, 2017

Authors:

A. J. van der Lely

R. Gomez

A. Pleil

Abstract

PurposeDespite availability of multimodal treatment options for acromegaly, achievement of long-term disease control is suboptimal in a significant number of patients. Furthermore, disease control as defined by biochemical normalization may not always show concordance with disease-related symptoms o...

View

Open Access

Subject

Medicine

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!